Streetbeat News

Regulatory

EFTR

Effector Therapeutics has been granted European Patent Number EP3888658, which covers EIF4-A-inhibiting compounds and methods related to their use for the treatment of cancer. This patent strengthens the company's intellectual property position in Europe and could potentially enhance its ability to develop and commercialize cancer treatments based on these compounds.

Portfolio Pulse from Benzinga Newsdesk

November 24, 2023 | 3:04 pm

EGPT

EIS

SPY

Israeli TV stations report that Israeli hostages have been transferred to Egyptians, according to Reuters citing the stations. No specific companies or ETFs are directly mentioned in relation to this geopolitical event.

Portfolio Pulse from Benzinga Newsdesk

November 24, 2023 | 2:50 pm

CSCO

MSFT

ZM

Zoom Video Communications Inc (NASDAQ:ZM) reported better-than-expected Q3 revenue and net income, leading to an increase in annual guidance. The company's integration of AI and strong enterprise sales contributed to its performance. Zoom's AI Companion has been enabled by over 220,000 accounts, and its Phone segment and Contact Center have shown growth. Despite facing criticism over terms of service changes and security issues, Zoom is competing in the business collaboration software market, aiming to challenge Microsoft Teams' dominance.

Portfolio Pulse from Upwallstreet

November 24, 2023 | 2:50 pm

EIS

A ceasefire between Israel and Hamas has begun on the 49th day of conflict, with a hostage and prisoner exchange agreement in place. The truce includes the release of 50 hostages by Hamas and 150 Palestinian prisoners by Israel. The first phase of the exchange has started, with 13 hostages released by Hamas and 39 Palestinian prisoners to be released by Israel. The Israel Defense Forces (IDF) are prepared to receive and provide medical support to the released hostages. Additionally, military movements have been observed, with Israeli tanks retreating and humanitarian aid entering Gaza. U.S. markets are on a shortened trading schedule due to Black Friday, with subdued activity. The iShares MSCI Israel ETF (EIS) closed with a 1.5% gain on Wednesday.

Portfolio Pulse from Piero Cingari

November 24, 2023 | 2:49 pm

NVOS

Novo Integrated Sciences, Inc. (NVOS) has regained compliance with Nasdaq's minimum bid price requirement. Nasdaq confirmed that NVOS's stock maintained a closing bid price of $1.00 or more for 11 consecutive business days, meeting the Listing Rule 5550(a)(2) for continued listing.

Portfolio Pulse from Benzinga Newsdesk

November 24, 2023 | 2:22 pm

VRTX

Vertex Pharmaceuticals has announced that the European Medicines Agency (EMA) has validated its Marketing Authorization Application (MAA) extension for KAFTRIO in combination with ivacaftor. This validation is a step towards making the treatment available to cystic fibrosis patients with responsive rare mutations in Europe.

Portfolio Pulse from Benzinga Newsdesk

November 24, 2023 | 2:17 pm

BLK

JPM

JPMorgan (NYSE:JPM) has released a research report expressing a positive view on the settlement between Binance and the U.S. government, which is expected to reduce systemic risks and attract traditional finance investors to the crypto sector. The settlement is seen as a move towards regulation, which could reverse Binance's recent market share loss and positively impact its trading operations and BNB Smart Chain business. Major asset managers like BlackRock (NYSE:BLK) are involved in the process of approving Bitcoin ETFs, indicating a trend towards regulated crypto entities.

Portfolio Pulse from Murtuza Merchant

November 24, 2023 | 1:49 pm

AMZN

IRBT

iRobot shares have risen after reports indicated that Amazon's planned acquisition of the company is expected to receive unconditional approval from EU antitrust authorities.

Portfolio Pulse from Benzinga Newsdesk

November 24, 2023 | 1:40 pm

YOSH

Yoshiharu Global Co. (NASDAQ:YOSH), a California-based Japanese ramen restaurant operator, announced a 1-for-10 reverse stock split to regain compliance with Nasdaq's Minimum Bid Price Requirement. The split will be effective on November 27, 2023, with trading on a post-split basis starting November 28, 2023. The split was approved by stockholders and the Board, reducing Class A and Class B common stock to 1,194,000 and 100,000 shares respectively. Adjustments will be made to outstanding equity awards, warrants, and exercise prices. No fractional shares will be issued, and the authorized capital stock will remain unchanged.

Portfolio Pulse from Benzinga Newsdesk

November 24, 2023 | 1:33 pm

PBH

Insight Pharmaceuticals, a subsidiary of Prestige Consumer Healthcare, has issued a voluntary nationwide recall of TING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder. The recall is due to the detection of benzene, a known carcinogen, in the product. This recall may affect the company's reputation and could lead to financial implications due to potential returns, legal action, or regulatory penalties.

Portfolio Pulse from Benzinga Newsdesk

November 24, 2023 | 1:32 pm